SCHEMBL21568317

SCHEMBL21568317

COC(=O)c1ccc2nc(NC(=O)Nc3cccc(N=O)c3)sc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 1/20 0.60
▸ PIK3CB P42338 1/20 0.60
▸ PIK3CG P48736 1/20 0.60
▸ PI4KB Q9UBF8 1/20 0.60
▸ HTT P42858 4/20 0.58
▸ NPC1 O15118 7/20 0.57
▸ RAB9A P51151 7/20 0.57
▸ SMN1; SMN2 Q16637 7/20 0.57
▸ HSP90AA1 P07900 1/20 0.56
▸ SCD O00767 1/20 0.56
▸ DYRK1A Q13627 2/20 0.55
▸ DYRK1B Q9Y463 2/20 0.55
▸ MEN1 O00255 5/20 0.55
▸ LMNA P02545 5/20 0.55
▸ MAPT P10636 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ POLB P06746 3/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ NFKB2 Q00653 1/20 0.55
▸ RELA Q04206 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21568117 0.83 DYRK1A (0.60) HTTNPC1RAB9ASMN1; SMN2DYRK1A
SCHEMBL31637616 0.83 PIK3CA (0.59) PIK3CAPIK3CBPIK3CGPI4KBHTT
SCHEMBL21568693 0.78 DYRK1A (0.55) PIK3CAPIK3CGHTTNPC1RAB9A
SCHEMBL21568314 0.77 LDHA (0.61) HTTNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL21568155 0.76 SMN1; SMN2 (0.66) HTTNPC1RAB9ASMN1; SMN2DYRK1A
SCHEMBL23357 0.75 RAB9A (0.84) HTTNPC1RAB9ASMN1; SMN2SCD
SCHEMBL21568136 0.74 NPC1 (0.62) NPC1RAB9ASMN1; SMN2DYRK1ADYRK1B
SCHEMBL19202176 0.73 PIK3CA (0.75) PIK3CAPIK3CBPIK3CGPI4KBHTT
SCHEMBL5534541 0.73 HTT (1.00) PIK3CAPIK3CBPIK3CGPI4KBHTT
SCHEMBL15427000 0.73 NPC1 (1.00) PIK3CAPIK3CBPIK3CGPI4KBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019217509-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER HB THERAPEUTICS INC. (US) 2019-11-14 — — WO disclosed
Send feedback